摘要
目的探究消化性溃疡的临床治疗中采用康复新液治疗的效果。方法40例消化性溃疡患者,随机分为对照组和治疗组,每组20例。对照组患者采用泮托拉唑治疗,治疗组患者采用康复新液联合泮托拉唑治疗。比较两组患者的治疗效果、临床症状积分、不良反应发生情况。结果治疗组患者治疗总有效率为95.00%,高于对照组的60.00%,差异具有统计学意义(P<0.05)。治疗后,治疗组患者胃脘疼痛、嗳气吞酸、食少便溏积分分别为(0.67±0.08)、(0.98±0.09)、(0.64±0.07)分,低于对照组的(1.89±0.45)、(2.34±0.51)、(1.34±0.38)分,差异具有统计学意义(P<0.05)。治疗组患者不良反应发生率为5.00%,低于对照组的35.00%,差异具有统计学意义(P<0.05)。结论消化性溃疡患者单纯用药的治疗效果不佳,在泮托拉唑治疗基础上联合康复新液治疗效果显著,降低了患者的临床症状积分,减少了不良反应,值得临床推广应用。
Objective To investigate the effect of Kangfuxin liquid in clinical treatment of peptic ulcer.Methods A total of 40 peptic ulcer patients were randomly divided into control group and treatment group,with 20 cases in each group.The control group was treated by pantoprazole,and the treatment group was treated by Kangfuxin liquid combined with pantoprazole.The therapeutic effect,clinical symptom integral and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment of the treatment group was 95.00%,which was higher than that of the control group 60.00%,and the difference was statistically significant(P<0.05).After treatment,the epigastric pain,belching and acid swallowing and loose stool integral of the treatment group were(0.67±0.08),(0.98±0.09)and(0.64±0.07)points,which were all lower than those of the control group(1.89±0.45),(2.34±0.51)and(1.34±0.38)points,and the difference was statistically significant(P<0.05).The incidence of adverse reactions of the treatment group was 5.00%,which was lower than that of the control group 35.00%,and the difference was statistically significant(P<0.05).Conclusion The therapeutic effect of simple medication on patients with peptic ulcer is poor.Kangfuxin liquid combined with pantoprazole shows remarkable effect,which can lower the incidence of adverse reactions and reduce the occurrence of adverse reactions.It is worthy of clinical promotion and application.
作者
李建汉
陈嘉斌
肖东靖
LI Jian-han;CHEN Jia-bin;XIAO Dong-jing(Department Three of Internal Medicine,Luoding Hospital of Traditional Chinese Medicine,Luoding 527200,China)
出处
《中国实用医药》
2020年第14期107-109,共3页
China Practical Medicine